Thermoplastic resin composition for refrigerant transporting piping, and method for producing same
US-12071541-B2 · Aug 27, 2024 · US
US10141532B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10141532-B2 |
| Application number | US-201715590119-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 9, 2017 |
| Priority date | May 2, 2012 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to curable barrier encapsulants or sealants for electronic devices that have pressure sensitive adhesive properties. The encapsulants are especially suitable for organic electronic devices that require lower laminating temperature profiles. The encapsulant protects active organic/polymeric components within an organic electronic device from environmental elements, such as moisture and oxygen.
Opening claim text (preview).
We claim: 1. A curable encapsulant comprising: a) from about 70 to about 90 wt %, based on the total weight of the curable encapsulant, of a polyisobutylene having a Mw of from about 1,000 to about 95,000 Da; b) from about 10 to about 50 wt %, based on the total weight of the curable encapsulant, of a functionalized polyisobutylene having (i) a Mw of from about 1,000 to about 95,000 Da and (ii) greater than one free-radical reactive functional group per polymer chain, wherein the free-radical reactive functional group is selected from the group consisting of terminal (meth)acrylates and/or, terminal acrylates; c) a free radical initiator; and d) a UV absorber; wherein the curable encapsulant is (i) essentially free of an acrylic monomer with Mw less than about 1,000 Da or volatile organic compound with Mw less than about 1,000 Da, (ii) essentially free of a tackifier, and (iii) a hot melt. 2. The curable encapsulant of claim 1 , wherein the UV absorber is a selected from the group consisting of benzotriazole derivatives, hydroxybenzophenones, hydroxyphenyl triazines, esters of substituted and unsubstituted benzoic acids, hindered amine light stabilizer, and mixtures thereof. 3. The curable encapsulant of claim 2 , wherein the hindered amine light stabilizer is a secondary, tertiary, acetylated, N-hydrocarbyloxy substituted, hydroxyl-substituted N-hydrocarbyloxy substituted, or a substituted cyclic amine characterized by aliphatic substitution on the carbon atoms adjacent to the amine function. 4. The curable encapsulant of claim 1 further comprising a functionalized polyolefin, wherein the functionalized polyolefin has (i) a Mw of from about 1,000 to about 95,000 Da and (ii) greater than 1 free-radical reactive functional group; wherein the free-radical functional group is selected from the group consisting of terminal (meth)acrylates and/or terminal acrylates. 5. The curable encapsulant of claim 1 further comprising up to 20 wt % of a plurality of desiccant fillers. 6. The curable encapsulant of claim 1 which comprises less than 5,000 ppm of a volatile organic molecule having a Mw less than 1,000 Da. 7. A curable encapsulant comprising: a) from about 70 to about 90 wt %, based on the total weight of the curable encapsulant, a polyisobutylene having a Mw of from about 1,000 to about 95,000 Da; b) from about 10 to about 50 wt %, based on the total weight of the curable encapsulant, a functionalized polyolefin having (i) a Mw of from about 1,000 to about 95,000 Da and (ii) greater than one free-radical reactive functional group per polymer chain, wherein the free-radical reactive functional group is selected from the group consisting of terminal (meth)acrylates and/or, terminal acrylates; c) a free radical initiator; and d) a UV absorber wherein the curable encapsulant is (i) essentially free of an acrylic monomer with Mw less than about 1,000 Da or volatile organic compound with Mw less than about 1,000 Da, (ii) essentially free of a tackifier, and (iii) a hot melt. 8. The curable encapsulant of claim 7 , wherein the UV absorber is a selected from the group consisting of benzotriazole derivatives, hydroxybenzophenones, hydroxyphenyl triazines, esters of substituted and unsubstituted benzoic acids, hindered amine light stabilizer, and mixtures thereof. 9. The curable encapsulant of claim 7 , wherein the hindered amine light stabilizer is a secondary, tertiary, acetylated, N-hydrocarbyloxy substituted, hydroxyl-substituted N-hydrocarbyloxy substituted, or a substituted cyclic amine characterized by aliphatic substitution on the carbon atoms adjacent to the amine function. 10. The curable encapsulant of claim 7 wherein the functionalized polyolefin is selected from the group consisting of (meth)acrylate-terminated polybutadiene, hydrogenated (meth)acrylate-terminated polybutadiene, and mixtures thereof. 11. The curable encapsulant of claim 7 further comprising up to 20 wt % of a plurality of desiccant fillers. 12. The curable encapsulant of claim 7 which comprises less than 5,000 ppm of a volatile organic molecule having a Mw less than 1,000 Da. 13. A curable encapsulant comprising: a) from about 70 to about 90 wt %, based on the total weight of the curable encapsulant, an amorphous polyalphaolefin having a Brookfield viscosity less than 8,000 cps at 190° C.; b) from about 10 to about 50 wt %, based on the total weight of the curable encapsulant, a functionalized polyisobutylene or functionalized polyolefin having (i) a Mw of from about 1,000 to about 95,000 Da and (ii) greater than one free-radical reactive functional group per polymer chain, wherein the free-radical reactive functional group is selected from the group consisting of terminal (meth)acrylates and/or, terminal acrylates; c) a free radical initiator; d) a tackifier; and e) a UV absorber; wherein the functionalized polyolefin is selected from the group consisting of (meth)acrylate-terminated polybutadiene, hydrogenated (meth)acrylate-terminated polybutadiene, and mixtures thereof wherein the curable encapsulant is (i) essentially free of an acrylic monomer with Mw less than about 1,000 Da or volatile organic compound with Mw less than about 1,000 Da and (ii) a hot melt. 14. The curable encapsulant of claim 13 , wherein the UV absorber is a selected from the group consisting of benzotriazole derivatives, hydroxybenzophenones, hydroxyphenyl triazines, esters of substituted and unsubstituted benzoic acids, hindered amine light stabilizer, and mixtures thereof. 15. The curable encapsulant of claim 13 , wherein the hindered amine light stabilizer is a secondary, tertiary, acetylated, N-hydrocarbyloxy substituted, hydroxyl-substituted N-hydrocarbyloxy substituted, or a substituted cyclic amine characterized by aliphatic substitution on the carbon atoms adjacent to the amine function. 16. The curable encapsulant of claim 13 further comprising up to 20 wt % of a plurality of desiccant fillers. 17. An article comprising the curable encapsulant of claim 1 which is an electronic device. 18. An article comprising the curable encapsulant of claim 7 which is an electronic device. 19. An article comprising the curable encapsulant of claim 13 which is an electronic device.
Copolymers of isobutene; Butyl rubber; Homopolymers or copolymers of other iso-olefins · CPC title
Electricity · mapped topic
Electricity · mapped topic
containing three or more polymers in a blend · CPC title
from alkenes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.